Delivery Order SPE2DB20D9331-SPE2DB22FL1A9

Award Date 6/8/22
Potential Completion Date 6/30/22
Potential Value $40K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a $37,224.96 firm fixed-price delivery order for the supply of Xolair 150 mg/1.2 ml powder vials, a specialty pharmaceutical product. The award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,612.88 firm fixed-price delivery order is for Xolair 150 mg/1.2 ml powder, a specialized medication. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) under the DLA's SPE2DB program, which provides a comprehensive range of pharmaceutical items to fulfill the recurring...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $46,531.20 firm fixed-price delivery order is for the supply of Xolair 150 mg/1.2 ml powder vials, with an ultimate completion date of October 13, 2021. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $79,354.56 firm fixed-price delivery order is for the provision of XOLAIR 150 MG/1.2 ML POWDER VLS, a specialized biologic medication, to fulfill the recurring medical supply needs of military health facilities worldwide. The award is part of a larger $499,999,999 indefinite delivery contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $39,584.16 firm fixed-price delivery order is for the supply of XOLAIR 150 MG/1.2 ML POWDER VLS, a specialty pharmaceutical product. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $79,168.32 firm fixed-price delivery order is for the provision of 4,558,057,626 units of Xolair (150 mg/1.2 ml powder) to support the recurring medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $10,831.80, is a firm fixed-price delivery order for the supply of XOLAIR 150 MG/ML SYRINGE, a specialized pharmaceutical product. The award is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,204.16 delivery order is for the supply of Xolair 150 mg/1.2 ml powder vials, a specialty pharmaceutical product. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This single-award IDC allows the...
This federal contract award, valued at $18,568.80, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of Xolair 150 mg/1.2 ml powder vials, a specialized biologic medication. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
This federal contract award, valued at $7,737.00, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of Xolair 150 mg/mL syringes, a prescription medication used to treat certain respiratory conditions. The award is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA,...
  • SPE2DB20D9331
    Indefinite Delivery Contract
  • SPE2DB20D9331-SPE2DB22FL1A9
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $39,584.16 firm fixed-price delivery order is for the supply of Xolair 150 mg/1.2 ml powder vials, which are used to treat certain respiratory conditions.

The award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This single-award IDC allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. The contract has no set-aside designation.

Through this IDC and other prime vendor contracts, DMS Pharmaceutical Group provides both routine and critical medications, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the diverse medical requirements of the Department of Defense healthcare system.

Generated 1/9/25, 9:02 AM